Bullboard - Stock Discussion Forum Amphastar Pharmaceuticals Inc AMPH

Healthcare

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed... see more

Add To Watchlist

NDAQ:AMPH - Post Discussion

Amphastar Pharmaceuticals Inc > AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITI

View:

Post by AviseAnalytics on Mar 13, 2023 9:32am

AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITI

$AMPH

Excited to share an article about Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company focusing primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation and intranasal products.

Amphastar recently received approval for its New Drug Application (NDA) for naloxone hydrochloride nasal spray 4mg - this is expected to strengthen its already diversified product portfolio further and bring in even more revenue opportunities for the Company.

Read on to know more:

https://www.aviseanalytics.com/amphastar-new-fda-approval-opens-a-floodgate-of-opportunities/